All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the MPN Advocates Network.
The MPN Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the MPN Hub cannot guarantee the accuracy of translated content. The MPN Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
During the 49th Annual Meeting of the EBMT, the MPN Hub was pleased to speak to Jean-Jacques Kiladjian, Université de Paris - Hôpital Saint-Louis, Paris, FR. We asked, Is transplantation still the only curative treatment for myelofibrosis (MF)?
Is transplantation still the only curative treatment for MF?
In this interview, Kiladjian outlines the many obstacles to curing MF including the dynamic nature of driver mutations and the limited therapy options currently available. Moving forward, Kiladjian goes on to review emerging treatments that may be used in combination with existing therapies to achieve a potentially curative result in the future. Kiladjian concludes by discussing the indications and key safety considerations for the use of transplantation in MF.
Your opinion matters
Effect of allo-HSCT and BM fibrosis regression on OS in patients with MF
We summarize a poster presentation by Gandhi from the 2022 TCT Meetings of ASTCT and CIBMTR investigating the impact of pre-allo-HSCT splenomegaly, splenic irradiation, and pre-...
JAK inhibition in MPN: Updates from phase I/II trials at ASH 2022
Several exciting updates on developments in JAK inhibition for the treatment of MPN were presented at the 64th ASH Annual Meeting and Exposition. Here, we summarize key findings from...
Subscribe to get the best content related to MPN delivered to your inbox